WS #12620
Oatly shares rise on better-than-expected Q2 results and raised FY26 sales guidance. Trump proposes tariffs up to 200% on imported generic drugs after two-year grace period.
Oatly Q2 Beat
Oatly shares rise on better-than-expected Q2 results and raised FY26 sales guidance.
Trump proposes tariffs up to 200% on imported generic drugs after two-year grace period.